HIV/AIDS Community Innovation Program

HIV/AIDS Logo

It is estimated that more than 36 million adults and children are living with HIV/AIDS while approximately 15,000 more people are infected each day. Globally, more than 21 million people have died from AIDS, resulting in 13.2 million orphaned children.

GlaxoSmithKline Inc. (GSK) has a proud history of contributing to the fight against HIV/AIDS through the research and development of medicines that treat the disease, but recognizes that additional initiatives are needed to intensify and accelerate the response to HIV/AIDS.

The HIV/AIDS Community Innovation Program is a Canadian initiative coordinated by GSK and Shire. For more information on this program, visit the following links:

You may also be interested in Positive Action, an international program of HIV education, care and community support.

^ Back to top